Ramosetron

Ramosetron
	File:Ramosetron.svg
Clinical data
AHFS/Drugs.com	International Drug Names
Routes of; administration	Intravenous
ATC code	none;
Pharmacokinetic data
Elimination half-life	5.8 hours
Identifiers
	IUPAC name (1-methyl-1H-indol-3-yl)[(5R)-4,5,6,7-tetrahydro-1H-benzimidazol-5-yl]methanone;
CAS Number	132907-72-3 ;
PubChem CID	108000;
IUPHAR/BPS	2301;
UNII	7ZRO0SC54Y;
ChEMBL	ChEMBL1643895 ;
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
Formula	C17H17N3O
Molar mass	279.33 g/mol
(what is this?) (verify)

Ramosetron (INN) is a serotonin 5-HT₃ receptor antagonist for the treatment of nausea and vomiting.^[1] Ramosetron is also indicated for a treatment of “diarrhea-predominant irritable bowel syndrome in males”.^[2] In India it is marketed under the brand name of "IBset".

It is only licensed for use in Japan and selected Southeast Asian countries. It is commonly sold under the tradename Nasea and in India as Nozia (300 mcg/ml Inj. & 100 mcg Tab.) ^[3]

References

↑ Fujii Y, Saitoh Y, Tanaka H, Toyooka H (2000). "Ramosetron for preventing postoperative nausea and vomiting in women undergoing gynecological surgery". Anesth. Analg. 90 (2): 472–5. doi:10.1097/00000539-200002000-00043. PMID 10648342. Unknown parameter |month= ignored (help)
↑ http://www.astellas.com/en/corporate/news/detail/astellas-launches-irribow-for.html
↑ Abriged prescribing information - Nasea (MIMS Philippines). Retrieved on June 13, 2008.

Template:5-HT3 antagonists

[1] Fujii Y, Saitoh Y, Tanaka H, Toyooka H (2000). "Ramosetron for preventing postoperative nausea and vomiting in women undergoing gynecological surgery". Anesth. Analg. 90 (2): 472–5. doi:10.1097/00000539-200002000-00043. PMID 10648342. Unknown parameter |month= ignored (help)

[2] ttp://www.astellas.com/en/corporate/news/detail/astellas-launches-irribow-for.html

[3] Abriged prescribing information - Nasea (MIMS Philippines). Retrieved on June 13, 2008.

[1]

[2]

[3]

Ramosetron

References

Navigation menu